Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick H Davidorf

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Custom-made "Nag" eye plaques for 125I brachytherapySubir Nag, Dian Wang, Hong Wu, et al.
Experimental Eye Research|September 28, 2011
Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimensBenjamin N Christopher, Colleen M Cebulla, Paul E Wakely, et al.
Melanoma Research|March 18, 2011
Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predispositionMohamed H Abdel-Rahman, Robert Pilarski, James B Massengill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanomaMohamed H Abdel-Rahman, Ying Yang, Xiao-Ping Zhou, et al.
Molecular Vision|August 28, 2004
Delivery of antiangiogenic and antioxidant drugs of ophthalmic interest through a nanoporous inorganic filterKathleen E Orosz, Somil Gupta, Marla Hassink, et al.
Investigative Ophthalmology & Visual Science|June 8, 2019
Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 MutationsGetachew Boru, Colleen M Cebulla, Klarke M Sample, et al.
Familial Cancer|January 6, 2021
Atypical choroidal nevus in a subject with a germline PALB2 pathogenic variantTimothy W Grosel, Matthew Karl, Robert T Pilarski, et al.
Experimental Eye Research|May 10, 2012
Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survivalMohamed H Abdel-Rahman, Colleen M Cebulla, Vishal Verma, et al.
Genes, Chromosomes & Cancer|May 16, 2018
Analysis of the exome aggregation consortium (ExAC) database suggests that the BAP1-tumor predisposition syndrome is underreported in cancer patientsJames B Massengill, Klarke M Sample, Robert Pilarski, et al.
Brachytherapy|November 4, 2015
Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapyC Ellis Wisely, Mersiha Hadziahmetovic, Rachel E Reem, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Custom-made "Nag" eye plaques for 125I brachytherapySubir Nag, Dian Wang, Hong Wu, et al.
Experimental Eye Research|September 28, 2011
Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimensBenjamin N Christopher, Colleen M Cebulla, Paul E Wakely, et al.
Melanoma Research|March 18, 2011
Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predispositionMohamed H Abdel-Rahman, Robert Pilarski, James B Massengill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanomaMohamed H Abdel-Rahman, Ying Yang, Xiao-Ping Zhou, et al.
Molecular Vision|August 28, 2004
Delivery of antiangiogenic and antioxidant drugs of ophthalmic interest through a nanoporous inorganic filterKathleen E Orosz, Somil Gupta, Marla Hassink, et al.
Investigative Ophthalmology & Visual Science|June 8, 2019
Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 MutationsGetachew Boru, Colleen M Cebulla, Klarke M Sample, et al.
Familial Cancer|January 6, 2021
Atypical choroidal nevus in a subject with a germline PALB2 pathogenic variantTimothy W Grosel, Matthew Karl, Robert T Pilarski, et al.
Experimental Eye Research|May 10, 2012
Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survivalMohamed H Abdel-Rahman, Colleen M Cebulla, Vishal Verma, et al.
Genes, Chromosomes & Cancer|May 16, 2018
Analysis of the exome aggregation consortium (ExAC) database suggests that the BAP1-tumor predisposition syndrome is underreported in cancer patientsJames B Massengill, Klarke M Sample, Robert Pilarski, et al.
Brachytherapy|November 4, 2015
Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapyC Ellis Wisely, Mersiha Hadziahmetovic, Rachel E Reem, et al.
Pageof 4